Ph.D. Duquesne University 1977
Master of Public Health Indiana University 1992
Improving medication use and safety in people with chronic diseases, factors affecting patient adherence to their chronic medications, pharmacoepidemiology of chronically administered medications, pharmacy services research in ambulatory settings, health care utilization of low-income minority people with chronic diseases
National Institute on Aging
Blue Cross Blue Shield of North Carolina
Murray MD. (2011). Curricular considerations for pharmaceutical comparative effectiveness research. Pharmacoepidemiology Drug Safety 2011 Jan.
Murray MD and Harrison J. (2010). Prescription abandonment: another path to medication nonadherence. Ann Intern Med (10): 680-681.
Aljadhey H, Tu W, Hansen RA, Blalock S, Brater C, and Murray MD. (2010). Risk of hyperkalemia associated with selective COX-2 inhibitors. Pharmacoepidemiology and Drug Safety 19: 194-98.
Murray MD. (2010). Implementing pharmacy practice programs for the management of heart failure. Pharm World Sci 32(5): 546-548.
Roth AM, Ackermann RT, Downs SM, Downs AM, Zillich AJ, Holmes AM, Katz BP, Murray MD, and Inui TS. (2010). The Structure and Content of Telephonic Scripts Used Effectively in the Indiana Medicaid Chronic Disease Management Program. Chronic Illness 6: 83-88.
Gandhi TK, Seger AC, Overhage JM, Murray MD, Hope C, Fiskio J, Teal E, and Bates DW. (2010). Outpatient adverse drug events identified using electronic health record screening. J Patient Safety 6(2): 91-96.
Report a Problem